Frontier Zdravlje Signs License Agreement with Medicines Patent Pool for nirmatrelvir

Frontier Zdravlje announces the signing of a license agreement with the Medicines Patent Pool (MPP) for a generic version of nirmatrelvir, the novel oral COVID-19 antiviral medicine (PF-07321332) developed by Pfizer, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir). This sub-license agreement is the outcome of a licensing agreement signed between MPP and Pfizer in November 2021 to facilitate affordable global access to nirmatrelvir; ritonavir.

Successful visit supporting the World Pharmacy Students Exchange Program

As part of the World Exchange Program of Pharmacy and Pharmaceutical Sciences Students (SEP) and the International Pharmacy Students Federation (IPSF) project, which this year marks the 70th anniversary of the first successfully held exchange, Frontier Zdravlje, in coordination with the National Association of Pharmacy Students of Serbia, realized a visit of the group of 11 pharmacy students from France, Poland and Serbia.

Zdravlje Expands Global Footprint

Zdravlje is excited to announce the launch of the Company’s international expansion strategy with the opening of new commercial offices in Bulgaria, Bosnia & Herzegovina and Montenegro. This significant development represents Zdravlje’s return to its own international commercial activities after almost two decades.

Leskovac Tandem with Zdravlje at the Paralympic Games in Tokyo

Already as a tradition, this year Zdravlje supports the members of the Cycling Club Dubocica from Leskovac, Milan Petrovic and Goran Smelcerovic, who will defend the colors of Serbia and Leskovac for the second time, this year at the Paralympic Games in Tokyo, from 24 August to 5 September 2021.